1. Albain K, Rush V, Crowley J, Turrisi A, Rice T, Livingston R (1994) Concurrent cisplatin/etoposide + chest radiation followed by surgery for stage 3A (N2) and 3B non-small cell lung cancer: completed analysis of SWOG-8805. Proc Am Soc Clin Oncol 13:337
2. Albain KS, Rusch VW, Crowley JJ, Rice TW, Turrisi AT 3rd, Weick IK, Lonchyna VA, Presant CA, McKenna RI, Gandara DR, et al. (1995) Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB nonsmall-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 13: 1880–1892
3. Breton JL, Westeel V, Milleron B, Moro-Sibilot D, Braun D, Quoix E, Lebeau B, Lernarié E, Depierre A (2001) Postoperative morbidity and mortality after neoadjuvant chemotherapy (NCT) for non-small cell lung cancer (NSCLC) in the French phase III trial. Proc Am Soc Clin Oncol 20:311a
4. Bunn P, Mault J, Kelly K (2000) Adjuvant and neoadjuvant chemotherapy for non-small cell lung cancer: a time for reassessment? Chest 117: 119S–122S
5. Choi NC, Carey RW, Daly W, Mathisen D, Wain J, Wright C, Lynch T, Grossbard M, Grillo H (1997) Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer. J Clin Oncol 15: 712–722